«US PLANS TO CLASSIFY MARIJUANA AS A LOW RISK DRUG»

The administration of the president Joe Biden has announced plans for reclassify the dope, assigning a risk level similar to that of medicines low recipe, Like the anabolic steroids. This initiative mark a significant change in the drug policy of USA, reflecting a perspective further modern and less punitive according to the dope.

A Change in Classification

According to cited sources by American media, the Drug Enforcement Administration (DEA) will approve a order issued by the Department of Health and Human Services (HHS). This order proposes moving the dope of one high restriction category to one less strict. Currently, the dope this classified under the same category that drugs highly dangerous as the heroin, the methamphetamines and the LSD, a categorization which dates from 1971.

Context and Comparison

For more than 50 years, the dope has shared a extremely restrictive classification, what has limited his Medical Investigation and his Therapeutic use despite its growing social and medical acceptance. Comparatively, the anabolic steroids, but also regulated, they do not face the same draconian restrictions. The reclassification proposal suggests a alignment of the dope with medicines Even though controlled, are considered manageable low medical prescription.

BUY THE BEST CBD PRODUCTS HERE

State Legalization

He legal landscape in USA already shows a significant diversity in the regulation of the dope. At the moment, 24 states allow your recreational use for people older than 21 years, and others 13 states they have legalized the dope for medical uses. This disparity reflects a gradual evolution and fragmented to the acceptance and regulation of the cannabis.

Implications of Change

Reclassify the dope could have multiple benefits. First of all, would facilitate the scientific investigation about they potential medical benefits, allowing studies further wide and rigorous. Furthermore, it could reduce the criminal sanctions associated with his possession and use, relieving burden about him judicial system and prisoner from the country.

Reactions and Perspectives

The extent has been received with divided opinions. The defenders of the medical and recreational marijuana come this one change as a positive step to the standardization and acceptance of the substance. On the other hand, some conservative sectors and groups worried about the public health warn about the possible risks of a freer access to the dope.

In summary, the proposal of the Biden administration of reclassify the dope represents a Advance to a drug policy further balanced and based on evidence. This motion could harmonize the federal regulation with the state trends and social, promoting a approach further rational and less punitive to him cannabis.